Renal denervation in an animal model of diabetes and hypertension: Impact on the autonomic nervous system and nephropathy

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Dias, Lucinara D ^a   Casali, Karina R ^a   Leguisamo, Natalia M ^a   Azambuja, Felipe ^a   Souza, Martina S ^b   Okamoto, Maristela ^c   Machado, Ubiratan F ^c   Irigoyen, Maria C ^c   Schaan, Beatriz D ^a,b  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 2; STREPTOZOCIN; SLC2A2 PROTEIN, RAT;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HEART RATE; HEART RATE VARIABILITY; HYPERTENSION; INJECTION; KIDNEY; KIDNEY DENERVATION; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; AUTONOMIC DENERVATION; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; REFLEX; TIME;

ALBUMINURIA; ANALYSIS OF VARIANCE; ANIMALS; AUTONOMIC DENERVATION; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLUCOSE TRANSPORTER TYPE 2; HEART RATE; HYPERTENSION; KIDNEY; MALE; RATS; RATS, INBRED SHR; REFLEX; TIME FACTORS;

EID: 79955088433     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-33     Document Type: Article

References (47)

1. Dall'Ago P, Fernandes TG, Machado UF, Bello AA, Irigoyen MC. Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res 1997, 30(1):119-124.
2. Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short-term experimental diabetes. Hypertension 1995, 26(6 Pt 2):1100-1104.
3. Schaan BD, Maeda CY, Timm HB, Medeiros S, Moraes RS, Ferlin E, Fernandes TG, Ribeiro JP, Schmid H, Irigoyen MC. Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulin. Braz J Med Biol Res 1997, 30(9):1081-1086. 10.1590/S0100-879X1997000900006, 9458968.
4. Schaan BD, Dall'Ago P, Maeda CY, Ferlin E, Fernandes TG, Schmid H, Irigoyen MC. Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats. Braz J Med Biol Res 2004, 37(12):1895-1902. 10.1590/S0100-879X2004001200016, 15558197.
5. Widdop RE, Verberne AJ, Jarrott B, Louis WJ. Impaired arterial baroreceptor reflex and cardiopulmonary vagal reflex in conscious spontaneously hypertensive rats. J Hypertens 1990, 8(3):269-275. 10.1097/00004872-199003000-00009, 2159508.
6. Farah VM, De Angelis K, Joaquim LF, Candido GO, Bernardes N, Fazan R, Schaan BD, Irigoyen MC. Autonomic modulation of arterial pressure and heart rate variability in hypertensive diabetic rats. Clinics 2007, 62(4):477-482. 10.1590/S1807-59322007000400015, 17823711.
7. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993, 16(5):773-779. 10.2337/diacare.16.5.773, 8495619.
8. Parving HH, Andersen AR, Smidt UM, Friisberg B, Svendsen PA. Reduced albuminuria during early and aggressive antihypertensive treatment of insulin-dependent diabetic patients with diabetic nephropathy. Diabetes Care 1981, 4(4):459-463. 10.2337/diacare.4.4.459, 7049630.
9. Bertoluci MC, Schmid H, Lachat JJ, Coimbra TM. Transforming growth factor-beta in the development of rat diabetic nephropathy. A 10-month study with insulin-treated rats. Nephron 1996, 74(1):189-196. 10.1159/000189300, 8883039.
10. Schaan BD, Irigoyen MC, Bertoluci MC, Lima NG, Passaglia J, Hermes E, Oliveira FR, Okamoto M, Machado UF. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes. Nephron Physiol 2005, 100(3):p43-50. 10.1159/000085413, 15855808.
11. Souza MS, Machado UF, Okamoto M, Bertoluci MC, Ponpermeyer C, Leguisamo N, Azambuja F, Irigoyen MC, Schaan BD. Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats. Braz J Med Biol Res 2008, 41(11):960-968. 10.1590/S0100-879X2008001100004, 19099149.
12. Schaan BD, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. Horm Metab Res 2001, 33(11):664-669. 10.1055/s-2001-18683, 11733869.
13. Schaan BD, Irigoyen MC, Lacchini S, Moreira ED, Schmid H, Machado UF. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats. Auton Neurosci 2005, 117(1):54-61. 10.1016/j.autneu.2004.11.001, 15620570.
14. Schaan BD, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. Auton Neurosci 2003, 104(2):88-94. 10.1016/S1566-0702(02)00295-3, 12648610.
15. Salman IM, Ameer OZ, Sattar MA, Abdullah NA, Yam MF, Abdullah GZ, Abdulkarim MF, Hye Khan MA, Johns EJ. Renal sympathetic nervous system hyperactivity in early streptozotocin-induced diabetic kidney disease. Neurourol Urodynam 30(3):438-446.
16. Schmidt RE, Scharp DW. Axonal dystrophy in experimental diabetic autonomic neuropathy. Diabetes 1982, 31(9):761-770. 10.2337/diabetes.31.9.761, 7160544.
17. Felten SY, Peterson RG, Shea PA, Besch HR, Felten DL. Effects of streptozotocin diabetes on the noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study. Brain Res Bull 1982, 8(6):593-607. 10.1016/0361-9230(82)90086-7, 6754009.
18. NIH Guide for the Care and Use of Laboratory Animals. 1996, Washingtion, DC: National Academy Press, NIH.
19. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991, 84(2):482-492.
20. Montano N, Porta A, Cogliati C, Costantino G, Tobaldini E, Casali KR, Iellamo F. Heart rate variability explored in the frequency domain: a tool to investigate the link between heart and behavior. Neurosci Biobehav Rev 2009, 33(2):71-80. 10.1016/j.neubiorev.2008.07.006, 18706440.
21. Stauss HM. Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol 2007, 34(4):362-368. 10.1111/j.1440-1681.2007.04588.x, 17324151.
22. Fazan R, de Oliveira M, da Silva VJ, Joaquim LF, Montano N, Porta A, Chapleau MW, Salgado HC. Frequency-dependent baroreflex modulation of blood pressure and heart rate variability in conscious mice. Am J Physiol Heart Circ Physiol 2005, 289(5):H1968-1975. 10.1152/ajpheart.01224.2004, 15951338.
23. Freitas HS, Schaan BD, da Silva RS, Okamoto MM, Oliveira-Souza M, Machado UF. Insulin but not phlorizin treatment induces a transient increase in GLUT2 gene expression in the kidney of diabetic rats. Nephron Physiol 2007, 105(3):p42-51. 10.1159/000098442, 17204838.
24. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ, Banks RE. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005, 5(2):566-571. 10.1002/pmic.200400941, 15627964.
25. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother 1(2):94-99. 10.4103/0976-500X.72351, 3043335, 21350617.
26. Rodgers RL. Depressor effect of diabetes in the spontaneously hypertensive rat: associated changes in heart performance. Can J Physiol Pharmacol 1986, 64(9):1177-1184.
27. DiBona GF. Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 2005, 289(3):R633-641. 10.1152/ajpregu.00258.2005, 16105818.
28. Osborn JL, Plato CF, Gordin E, He XR. Long-term increases in renal sympathetic nerve activity and hypertension. Clin Exp Pharmacol Physiol 1997, 24(1):72-76. 10.1111/j.1440-1681.1997.tb01786.x, 9043809.
29. Oliveira VL, Irigoyen MC, Moreira ED, Strunz C, Krieger EM. Renal denervation normalizes pressure and baroreceptor reflex in high renin hypertension in conscious rats. Hypertension 1992, 19(2 Suppl):II17-21.
30. Lee JY, Walsh GM. Systemic and regional haemodynamic effects of renal denervation in spontaneously hypertensive rats. J Hypertens 1983, 1(4):381-386. 10.1097/00004872-198312000-00010, 6681180.
31. Boku A, Sugimura M, Morimoto Y, Hanamoto H, Niwa H. Hemodynamic and autonomic response to acute hemorrhage in streptozotocin-induced diabetic rats. Cardiovasc Diabetol 9:78. 10.1186/1475-2840-9-78, 3004820, 21106105.
32. Balbinott AW, Irigoyen MC, Santos MS, Zottis B, Gianni de Lima N, Passaglia J, Schaan BD. Dose-dependent autonomic dysfunction in chronic L-NAME-hypertensive diabetic rats. J Cardiovasc Pharmacol 2005, 1:1-6.
33. Fazan R, Ballejo G, Salgado MC, Moraes MF, Salgado HC. Heart rate variability and baroreceptor function in chronic diabetic rats. Hypertension 1997, 30(3 Pt 2):632-635.
34. Fazan R, Dias da Silva VJ, Ballejo G, Salgado HC. Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats. J Hypertens 1999, 17(4):489-495. 10.1097/00004872-199917040-00006, 10404950.
35. Xie HH, Shen FM, Zhang XF, Jiang YY, Su DF. Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs. Eur J Pharmacol 2006, 543(1-3):77-82. 10.1016/j.ejphar.2006.05.034, 16808912.
36. Cerutti C, Gustin MP, Paultre CZ, Lo M, Julien C, Vincent M, Sassard J. Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am J Physiol 1991, 261(4 Pt 2):H1292-1299.
37. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986, 59(2):178-193.
38. Stauss HM, Mrowka R, Nafz B, Patzak A, Unger T, Persson PB. Does low frequency power of arterial blood pressure reflect sympathetic tone?. J Auton Nerv Syst 1995, 54(2):145-154. 10.1016/0165-1838(94)00000-A, 7499726.
39. Kopp UC, Jones SY, DiBona GF. Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 2008, 295(6):R1882-1890. 10.1152/ajpregu.90529.2008, 2685303, 18945951.
40. Oliveira VL, Moreira ED, Farah VD, Consolim-Colombo F, Krieger EM, Irigoyen MC. Cardiopulmonary reflex impairment in experimental diabetes in rats. Hypertension 1999, 34(4 Pt 2):813-817.
41. Chang KS, Lund DD. Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats. J Mol Cell Cardiol 1986, 18(6):617-624. 10.1016/S0022-2828(86)80969-5, 3525850.
42. Farah VM, Moreira ED, Pires MD, Irigoyen MC, Krieger EM. Comparison of three methods for the determination of baroreflex sensitivity in conscious rats. Braz J Med Biol Res 1999, 32(3):361-369. 10.1590/S0100-879X1999000300018, 10347797.
43. Asada T, Ogawa T, Iwai M, Shimomura K, Kobayashi M. Recombinant insulin-like growth factor I normalizes expression of renal glucose transporters in diabetic rats. Am J Physiol 1997, 273(1 Pt 2):F27-37.
44. Vestri S, Okamoto MM, de Freitas HS, Aparecida Dos Santos R, Nunes MT, Morimatsu M, Heimann JC, Machado UF. Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol 2001, 182(2):105-112. 10.1007/s00232-001-0036-y, 11447502.
45. Ramchandra R, Barrett CJ, Guild SJ, Malpas SC. Is the chronically denervated kidney supersensitive to catecholamines?. Am J Physiol Regul Integr Comp Physiol 2002, 282(2):R603-610.
46. Dai S, Lee S, Battell M, McNeill JH. Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration. Can J Cardiol 1994, 10(5):562-570.
47. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903-1909.